Clinical Trials
187 trialsPh. I/II Sodium Thiosulfate for OtoProtection During Cisplatin (STOP-CIS)
University of Arizona
ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer
The First Affiliated Hospital of Xiamen University
Smoking Cessation Treatment for Head & Neck Cancer Patients
M.D. Anderson Cancer Center
H&NANCE
Istituto Italiano di Tecnologia
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
THYSU
University Hospital, Bordeaux
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
Medical University of South Carolina
Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
Vanderbilt-Ingram Cancer Center
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Cancer Research UK
High-Resolution PET-CT Imaging for Surgical Margin Visualization
Vanderbilt-Ingram Cancer Center
CABOTHYROID
Grupo Espanol de Tumores Neuroendocrinos
CHEMOVES
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
RAISE
Children's Hospital of Philadelphia
ReRT
The New York Proton Center
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors
Icahn School of Medicine at Mount Sinai
Upfront Neck Dissection Before Radiotherapy in Stage N3 Nasopharyngeal Carcinoma: A Retrospective Study
Taichung Veterans General Hospital
NBI-CAB
Centre Oscar Lambret
Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy
IRCCS Azienda Ospedaliero-Universitaria di Bologna
SPAR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
M.D. Anderson Cancer Center
MOMENTUM
UMC Utrecht
EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study
Università Cattolica di Milano
PORTICO
Luzerner Kantonsspital
QVA-Mod
Hospices Civils de Lyon
DETERMINE
Cancer Research UK
Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Sichuan Enray Pharmaceutical Sciences Company
ONE TEAM
Duke University
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
UNC Lineberger Comprehensive Cancer Center
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
Dana-Farber Cancer Institute
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
ORARAD II
Wake Forest University Health Sciences
PharmTRT
Hospices Civils de Lyon
Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck
University of California, San Diego
EMITT-1
Grey Wolf Therapeutics
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
Georgetown University
Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
University of California, Davis
A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes
University Health Network, Toronto
MASST
University Health Network, Toronto
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
M.D. Anderson Cancer Center
LAXER
Universidad de Granada
Potlako+
Brigham and Women's Hospital
CIRADOR
Institut de Cancérologie de Lorraine
FAISA-CORPPS
University Hospital, Lille
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Memorial Sloan Kettering Cancer Center
DETERMINE
Cancer Research UK
LIBERATE
University Health Network, Toronto
DETERMINE
Cancer Research UK
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Children's Hospital of Philadelphia
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Children's Hospital of Philadelphia
AYAConnect
UNC Lineberger Comprehensive Cancer Center